Abstract
AbstractRDW is an erythrocyte index that increase in multiple myeloma, in which it appears to have an important role in predicting outcome. For this reason, we performed a retrospective analysis to evaluate the relationships of RDW with some important prognostic predictors. Specifically, in a cohort of 190 newly diagnosed multiple myeloma patients, we have examined the behaviour of RDW and its trend in relation to the ISS stage and other prognostic factors, such as albumin, beta-2 microglobulin, LDH and bone marrow plasma cell infiltration. We performed the analysis in the entire cohort of patients and in the three different disease isotypes (Light chain, IgA, and IgG multiple myeloma). The evaluation of RDW in the different isotypes was made with the Kruskal–Wallis test, integrated by the Dunn test. The comparison between the subgroups allocated above and below the median value of each prognostic factor, was made with the Mann–Whitney test. From our analysis, we observed that RDW is higher in the IgA multiple myeloma, and it increases significantly from ISS I to III. Moreover, RDW increases in the presence of lower albumin values, higher levels of beta2-microglobulin and LDH and in the presence of a greater bone marrow plasma cell infiltrate.
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Patel, H. H., Patel, H. R. & Higgins, J. M. Modulation of red blood cell population dynamics is a fundamental homeostatic response to disease. Am. J. Hematol. 90, 422–428. https://doi.org/10.1002/ajh.23982 (2015).
2. Vucinic, V. et al. The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia. Blood Adv. 5, 5584–5587. https://doi.org/10.1182/bloodadvances.2021005974 (2021).
3. Iriyama, N. et al. Higher red blood cell distribution width is an adverse prognostic factor in chronic-phase chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Anticancer Res. 35, 5473–5478 (2015).
4. Mao, X. L. et al. Higher red blood cell distribution width at diagnose is a simple negative prognostic factor in chronic phase-chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: A retrospective study. Medicine (Baltimore) 100, e24003. https://doi.org/10.1097/MD.0000000000024003 (2021).
5. Li, T. et al. Higher red blood cell distribution width is a poor prognostic factor for patients with chronic myeloid leukemia. Cancer Manage. Res. 13, 1233–1243. https://doi.org/10.2147/CMAR.S288589 (2021).